Literature DB >> 31713446

B-cell prolymphocytic leukemia successfully treated with B-cell receptor antagonists, but resistant to venetoclax.

Anna Christoforidou1, Zoe Bezirgiannidou1, George Vrachiolias1, Menelaos Papoutselis1, Emmanouil Spanoudakis1, Ιoannis Kotsianidis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31713446     DOI： 10.1080/10428194.2019.1689392

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

Review 1.  Zanubrutinib, rituximab and lenalidomide induces deep and durable remission in TP53-mutated B-cell prolymphocytic leukemia: a case report and literature review.

Authors:  Lijie Xing; Qiang He; Linna Xie; Hui Wang; Zengjun Li
Journal:  Haematologica       Date:  2022-05-01       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.